medigraphic.com
ISSN 2683-1678 (Print)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología

2023, Number 3

<< Back Next >>

Rev Latin Infect Pediatr 2023; 36 (3)

Evolution and budget impact of possible improvements in the Immunization Programme: Paraguay 2008-2020

Olivera I, Grau C, Lazarov L, Martínez C, Dibarboure H, López JG, Oddo C, Bianculli P

Language: Spanish
References: 33
Page: 116-125
PDF size: 264.30 Kb.


ABSTRACT

Introduction: vaccination programmes represent a comprehensive approach aimed at reducing or eliminating the impact of immunopreventable diseases. The aim of the present study was to evaluate the evolution of the Paraguay schedule, the expenditure on vaccines and to estimate the impact of potential improvements compared to the current schedule. Material and methods: the evolution of Paraguay's expanded programme on immunization between 2008 and 2020 was evaluated, the current scenario was described and compared with different alternative schemes. The results were expressed as the total relative budgetary impact of each scenario versus the current situation. Results: Paraguay had a significant evolution in its calendar. We estimated a growth of more than six times. The most demanding vaccination schedules in terms of budget were those related to combined childhood vaccines and the scenarios of aggregating several changes simultaneously. Conclusions: this is the first study to analyze the evolution of the vaccination schedule and estimate expenditure in Paraguay to estimate the economic impact of potential changes in the country's vaccination schedule. The variety of impacts of different biologicals were presented. The evidence generated in this study will support local and regional health systems in their decision-making in relation to vaccination campaigns.


REFERENCES

  1. Congreso de la Nación de Paraguay. Ley No 2310 / Protección infantil contra las enfermedades inmunoprevenibles [Internet]. Disponible en: https://www.bacn.gov.py/leyes-paraguayas/4983/ley-n-2310-proteccion-infantil-contra-las- enfermedades-inmuno-prevenibles

  2. Ministerio de Salud Pública y Bienestar Social. Programa Ampliado de Inmunizaciones Paraguay (PAI) [Internet]. [Citado 28 de julio de 2021]. Disponible en: https://www.mspbs.gov.py/pai.html

  3. Ministerio de Salud Pública y Bienestar Social. Programa Ampliado de Inmunizaciones. Experiencia de Paraguay en la toma de decisiones para la introducción de la vacuna de neumococo conjugada [Internet]. 2012. Disponible en: https://www.paho.org/hq/dmdocuments/2012/PCV-CTorres- ExpParaguay-ARG-Mar2012.pdf

  4. Hadler SC, Dietz V, Okwo-Bele JM, Cutts FT. Chapter 70 - Immunization in developing countries. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines (Fifth ed) [Internet]. Edinburgh: W.B. Saunders; 2008 [cited 28 July 2021]. p. 1541-1571. Available in: https://www.sciencedirect.com/science/article/pii/B978141603611150074X

  5. Mitchell C. PAHO/WHO Immunization Newsletter - Immunization in the Americas [Internet]. Pan American Health Organization/World Health Organization. 2011 [Cited 29 July 2021]. Available in: https://www3.paho.org/inb/index.php?option=com_content&view=article&id=13:immunizations-in- the-americas&Itemid=1031&lang=es

  6. Poder Legislativo de Paraguay. Ley No 4621/2012. Ley Nacional de Vacunas. El Congreso de la Nación Paraguaya sanciona con fuerza de Ley [Internet]. 2012. Disponible en: http://www.bacn.gov.py/archivos/3105/20150309121016.pdf.

  7. Ministerio de Salud Pública y Bienestar Social. Programa Ampliado de Inmunizaciones. Normas de Vacunación [Internet]. 2016. Disponible en: http://pai.mspbs.gov.py/images/documentos/manuales/2016/normasdelpai2016selection1.pdf

  8. Kroger A, Duchin J, Vazquez M. General Best Practice Guidelines for Immunization. Best Practices Guidance of the Advisory Committee on Immunizations Practices (ACIP) [Internet]. 12-49 p. Available in: https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/index.html

  9. Banco Mundial. GDP (Current US$) - Paraguay | Data [Internet]. [Citado 09 de septiembre de 2021]. Disponible en: https://data.worldbank.org/indicator/NY.GDP.MKTP.CD?locations=PY

  10. World Health Organization. World Health Organization. 41o World Health Assembly: Global eradication of poliomyelitis by the year 2000. Resolution WHO 41.28 Geneva [Internet]. 1988. Available in: http://www.who.int/ihr/polioresolution4128en.pdf

  11. Public Health Agency of Canada. Canadian Immunization Guide. Poliomyelitis Vaccine. Part 4. [Internet]. 2021. Available in: http://www.phac-aspc.gc.ca/publicat/cig-gci/p04-poli- eng.php#a5

  12. ACIP. Center for Disease Control and Prevention. Poliomyelitis Prevention in the United States. Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP). 2000; 49: 1-22.

  13. Ministerio de Salud Pública. Esquema de Vacunación en Uruguay [Internet] [Internet]. 2021. Disponible en: http://www.msp.gub.uy/noticia/vacunas

  14. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2019-20 Influenza Season. Morbidity and Mortality Weekly Report Recommendations and Reports. 2019. [Consulted 15 October 2019] Available in: https://www.cdc.gov/mmwr/volumes/68/rr/pdfs/rr6803-H.pdf

  15. World Health Organization. World Health Organization. Vaccines against influenza. WHO position paper. 2012; 87 (47): 461-476. Available in: https://www.who.int/wer/2012/wer8747.pdf?ua=1

  16. Ministerio de Salud Pública de Uruguay. Campaña de vacunación antigripal y antineumocócica 2020 en el marco del Plan Nacional [Internet]. 2020. Disponible en: https://www.gub.uy/ministerio-salud-publica/comunicacion/publicaciones/vacunas

  17. Ministerio de Salud de Chile. Campaña influenza 2020 [Internet]. 2020. Disponible en: https://www.minsal.cl/campana-influenza-2020/

  18. Ministerio de Salud de Chile. Calendario de vacunación 2019 [Internet]. 2019. Disponible en: https://vacunas.minsal.cl/calendario-de-vacunacion-2019

  19. Secretaría de Salud de México. Programa de vacunación universal y semanas nacionales de salud. Lineamientos generales 2019 [Internet]. 2019. Disponible en: https://www.gob.mx/cms/uploads/attachment/file/416064/Lineamientos_Generales_PVU_y_SNS_2 019.pdf

  20. World Health Organization null. Polio vaccines: WHO position paper, March 2016 recommendations. Vaccine. 2017; 35 (9): 1197-1199.

  21. Tarantola D. Poliomielitis, situación actual y políticas posteriores a la erradicación. En: Vacunas, prevención de enfermedades, protección de la salud. Editor Ciro A. de Quadros. Washington D.C. Publicación Técnica y científica No Organización Panamericana de la Salud. 2004; 596: 25-32.

  22. Decker D, Edwards K, Bogaerts H. Combination vaccines. 6.a ed. Saunders Elsevier; 2012, pp. 981-1007.

  23. Marcy SM. Pediatric combination vaccines: their impact on patients, providers, managed care organizations, and manufacturers. Am J Manag Care. 2003; 9 (4): 314-320.

  24. Ministerio de Salud de Panamá. Programa Ampliado de Inmunizaciones. Esquema Nacional de Inmunización 2017. [Internet]. 2017. Disponible en: http://www.minsa.gob.pa/sites/default/files/programas/esquema_nacional_de_vacunacion_2017_1. pdf

  25. Ministerio de Salud de la Nación. Recién Nacidos Prematuros: Vacuna Séxtuple Acelular. Lineamientos Técnicos Argentina [Internet]. 2013. Disponible en: http://www.msal.gob.ar/images/stories/bes/graficos/0000000444cnt-2013-10_lineamientos-sextuple-en-prematuros.pdf

  26. Boletines De Vigilancia-Programa Ampliado de Inmunizaciones PAI - Paraguay - Vacuna [Internet]. [Citado 27 de mayo de 2021]. Disponible en: http://pai.mspbs.gov.py/article/boletines-de- vigilancia

  27. Burman C, Serra L, Nuttens C, Presa J, Balmer P, York L. Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination. Hum Vaccin Immunother. 2019; 15 (2): 459-469. Available in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422514/

  28. Organización Panamericana de la Salud, Organización Mundial de la Salud. Fondo Rotatorio de la Organización Panamericana de la Salud [Internet] [Internet]. [citado 28 de julio de 2021]. Disponible en: https://www.paho.org/es/documentos/folleto-fondo-rotatorio-ops

  29. Banco Mundial. Current health expenditure (% of GDP) - Paraguay | Data [Internet]. [citado 9 de septiembre de 2021]. Disponible en: https://data.worldbank.org/indicator/SH.XPD.CHEX.GD.ZS?locations=PY

  30. Macías M, Lanata CF, Zambrano B, Gil AI, Amemiya I, Mispireta M, et al. Safety and immunogenicity of an investigational fully liquid hexavalent DTaP-IPV-Hep B-PRP-T vaccine at two, four and six months of age compared with licensed vaccines in Latin America. Pediatr Infect Dis J. 2012; 31 (8): e126-132.

  31. Syed YY. DTaP-IPV-HepB-Hib Vaccine (Hexyon®): an updated review of its use in primary and booster vaccination. Paediatr Drugs. 2019; 21 (5): 397-408.

  32. López P, Arguedas Mohs A, Abdelnour Vásquez A, Consuelo-Miranda M, Feroldi E, Noriega F, et al. A randomized controlled study of a fully liquid DTaP-IPV-HB-PRP-T hexavalent vaccine for primary and booster vaccinations of healthy infants and toddlers in Latin America. Pediatr Infect Dis J. 2017; 36 (11): e272-282.

  33. Lanata C, Zambrano B, Ecker L. Immunogenicity and safety of a fully liquid DTaP-IPV-Hep B- PRP-T Vaccine at 2-4-6 months of age in Peru. Journal of Vaccines & Vaccination [Internet]. 2012; 03 (01). Available in: https:// www.omicsonline.org/immunogenicity- and-safety-of-a-fully-liquid-dtap-ipv-hep-b-prp-t-vaccine-at-2-4-6-months-of-age-in-peru-2157- 7560.1000128.php?aid=5405




2020     |     www.medigraphic.com